Replies to post #378146 on Elite Pharmaceuticals Inc (ELTP)

[Destiny Defined]

Great info. Thanks for Sharon.

[The ELTP King]

It's in the press release. Not sure what you're talking about.


Elite Pharmaceuticals Reports Positive Results From A Pivotal Bioequivalence Study

NORTHVALE, NJ / February 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today reported positive results from pivotal fasted bioequivalence studies for an undisclosed generic drug product in a class of medications called antimetabolites . IQVIA reported annual sales for the twelve months ending December 2022 of $42 million for the generic market for this product.

I don't have access to any IQVIA sales data

[The ELTP King]

I'm enjoying it.

And please don't forget, this is pure speculation based on scant clues, for entertainment purposes only. Enjoy.

[The ELTP King]

Besides Vyvanse, is there any other drug that Elite can go after with their capabilities?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171538952

Thanks.


------------------------------------------------------------------------------------------------------------------------------------------